REPUBLIC ACT 6675

Republic act 6675

GENERICS ACT OF 1988

• Senate Bill No. 453
• House Bill No. 10900

• 25 August 1988 &
• 31 August 1988

• Drug Establishment

• 13 September 1988

- President Corazon C. Aquino

• Drug Outlets

• Essential Drugs List/National Drug Formulary

list of drugs prepared and periodically updated by the Department of Health on the basis of health conditions obtaining in the Philippines as well as on internationally accepted criteria

Section 5.

• Core List

list of drugs that meets the health care needs of the majority of the population

The Department of Health shall publish annually in at least two (2) newspapers of general circulation in the Philippines the generic names, and the corresponding brand names under which they are marketed, of all drugs and medicines available in the Philippines.

• Complementary List

list of alternative drugs used when there is no response to the core essential drug or when there is hypersensitivity reaction to the core essential drug or when for one reason or another, the core essential drug cannot be given

• Generic Drugs

drugs not covered by patent protection and which are labeled solely by their international non-proprietary or generic name

Section 1.

• Generics Act of 1988

Section 3.

• Generic Name/Generic Terminology

scientifically and internationally recognize active ingredients or by their official generic name

Section 4.

• Brand Name

• Active Ingredient

proprietary name given by the manufacturer to distinguish its product from those of competitors.

chemical component responsible for the claimed therapeutic effect of the pharmaceutical product

• Chemical Name

description of the chemical structure of the drug or medicine and serves as the complete identification of a compound

Example: N-(4-hydroxyphenyl)ethanamide

• Drug Product

finished product form that contains the active ingredients

(a) In the promotion of the generic names for pharmaceutical products, special consideration shall be given to drugs and medicines which are included in the Essential Drugs List to be prepared within one hundred eighty (180) days from approval of this Act and updated quarterly by the Department of Health on the basis of health conditions obtaining in the Philippines as well as on internationally accepted criteria.

Section 2.

• To promote, encourage and require the use of generic terminology in the importation, manufacture, distribution, marketing, advertising and promotion, prescription & dispensing of drugs.

(b) The exclusive use of generic terminology in the manufacture, marketing and sales of drugs and medicines, particularly those in the Essential Drugs List, shall be promoted through such a system of incentives as the Board of Investments jointly with the Department of Health and other government agencies as may be authorized by law, shall promulgate in accordance with existing laws, within one hundred eighty (180) days after approval of this Act.

• To ensure the adequate supply of drugs with the generic names at lowest possible cost and endeavor to make them available for free to indigent patients.

• To encourage the extensive use of drugs with generic names through a rational system of procurement and distribution.

• To emphasize the scientific basis for the use of drugs, in order that health professionals may become more aware & cognizant of their therapeutic effectiveness.

• To promote drug safety by minimizing duplication in medications and/or use of drugs with potentially adverse drug interactions.

REPUBLIC ACT 6675